BILL ANALYSIS                                                                                                                                                                                                    



                                                                  SCR 14
                                                                  Page  1

          Date of Hearing:   July 8, 2009 

                        ASSEMBLY COMMITTEE ON APPROPRIATIONS
                                Kevin De Leon, Chair

                   SCR 14 (Aanestad) - As Amended:  May 14, 2009  

          Policy Committee:                              RulesVote:7-0

          Urgency:     No                   State Mandated Local Program:  
          No     Reimbursable:              

           SUMMARY  

          This Resolution designates September 2009 as Prostate Cancer  
          Awareness Month to increase the awareness of the importance of  
          early detection and treatment of prostate cancer. 

           FISCAL EFFECT  

          No direct fiscal impact to designate Prostate Cancer Awareness  
          Month. 

           COMMENTS  

           1)Rationale  . This resolution designates September 2009 as  
            Prostate Cancer Awareness month to increase awareness of the  
            most common cancer in American men. In 2009 approximately  
            18,000 men in California will be diagnosed with prostate  
            cancer and 3,100 men will die of the disease. As with many  
            other cancers, there are many factors that may contribute to  
            risk for this type of cancer. These factors include age,  
            family history, diet, and a sedentary lifestyle. 

           2)Background  . Prostate cancer is a slow-growing tumor, with 85%  
            of cases diagnosed in the early stages of disease. Treatment  
            options for this type of cancer depend on whether a tumor has  
            spread. Radiation and surgery are common treatments in early  
            stages of the disease. During later stages of the disease,  
            when the tumor has spread beyond the prostate, hormone therapy  
            is used to lower androgen, the hormone associated with  
            prostate tumor growth. Following treatment, prostate cancer  
            survivors are required to continue with medical monitoring  
            several times a year and then annually to ensure cancerous  
            activity is not detected. 








                                                                  SCR 14
                                                                  Page  2


           Analysis Prepared by  :    Mary Ader / APPR. / (916) 319-2081